Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease.

Cipollari E, Szapary HJ, Picataggi A, Billheimer JT, Lyssenko CA, Ying GS, Shaw LM, Kling MA, Kaddurah-Daouk R, Rader DJ, Praticò D, Lyssenko NN; Alzheimer’s Disease Metabolomics Consortium.

J Alzheimers Dis. 2020 Feb 11. doi: 10.3233/JAD-191246. [Epub ahead of print]

PMID:
32065798
2.

Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.

MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW, St John Williams L, Tenenbaum JD, Blach C, Baillie R, Han X, Bhattacharyya S, Toledo JB, Schafferer S, Klein S, Koal T, Risacher SL, Kling MA, Motsinger-Reif A, Rotroff DM, Jack J, Hankemeier T, Bennett DA, De Jager PL, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn CM, Saykin AJ, Kastenmüller G, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

Alzheimers Dement. 2019 Jan;15(1):76-92. doi: 10.1016/j.jalz.2018.07.217. Epub 2018 Oct 15. Erratum in: Alzheimers Dement. 2019 Apr;15(4):604.

3.

A cross-sectional study of untreated depression and anxiety in cutaneous lupus erythematosus and dermatomyositis.

Achtman J, Kling MA, Feng R, Okawa J, Werth VP.

J Am Acad Dermatol. 2016 Feb;74(2):377-9. doi: 10.1016/j.jaad.2015.09.016. No abstract available.

4.

Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.

Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, Soares HD, Kling MA, Mailman M, Arnold SE, Narayan VA, Lee VM, Shaw LM, Baker D, Wittenberg GM, Trojanowski JQ, Wang LS.

Alzheimers Dement (Amst). 2015 Sep 1;1(3):339-348.

5.

Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.

Kim S, Nho K, Ramanan VK, Lai D, Foroud TM, Lane K, Murrell JR, Gao S, Hall KS, Unverzagt FW, Baiyewu O, Ogunniyi A, Gureje O, Kling MA, Doraiswamy PM, Kaddurah-Daouk R, Hendrie HC, Saykin AJ.

J Alzheimers Dis. 2016;49(4):991-1003. doi: 10.3233/JAD-150651.

6.

Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications.

Gold PW, Pavlatou MG, Michelson D, Mouro CM, Kling MA, Wong ML, Licinio J, Goldstein SA.

Transl Psychiatry. 2015 Jun 2;5:e576. doi: 10.1038/tp.2015.38.

7.

Subjective memory complaints, cognitive performance, and psychological factors in healthy older adults.

Steinberg SI, Negash S, Sammel MD, Bogner H, Harel BT, Livney MG, McCoubrey H, Wolk DA, Kling MA, Arnold SE.

Am J Alzheimers Dis Other Demen. 2013 Dec;28(8):776-83. doi: 10.1177/1533317513504817.

8.

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging.

Motsinger-Reif AA, Zhu H, Kling MA, Matson W, Sharma S, Fiehn O, Reif DM, Appleby DH, Doraiswamy PM, Trojanowski JQ, Kaddurah-Daouk R, Arnold SE.

Acta Neuropathol Commun. 2013 Jun 27;1:28. doi: 10.1186/2051-5960-1-28.

9.

Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease.

Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, Chen-Plotkin A, Wolk DA, Arnold SE.

J Neurol Sci. 2013 Oct 15;333(1-2):9-12. doi: 10.1016/j.jns.2013.05.028. Epub 2013 Aug 23.

10.

Insomnia in alcohol dependence: predictors of symptoms in a sample of veterans referred from primary care.

Chakravorty S, Grandner MA, Kranzler HR, Mavandadi S, Kling MA, Perlis ML, Oslin DW.

Am J Addict. 2013 May-Jun;22(3):266-70. doi: 10.1111/j.1521-0391.2012.12009.x.

11.

Alterations in metabolic pathways and networks in Alzheimer's disease.

Kaddurah-Daouk R, Zhu H, Sharma S, Bogdanov M, Rozen SG, Matson W, Oki NO, Motsinger-Reif AA, Churchill E, Lei Z, Appleby D, Kling MA, Trojanowski JQ, Doraiswamy PM, Arnold SE; Pharmacometabolomics Research Network.

Transl Psychiatry. 2013 Apr 9;3:e244. doi: 10.1038/tp.2013.18.

12.

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin V, Lee VM, Trojanowski JQ, Arnold SE.

Brain. 2012 Dec;135(Pt 12):3749-56. doi: 10.1093/brain/aws271. Epub 2012 Nov 30.

13.

Vascular disease and dementias: paradigm shifts to drive research in new directions.

Kling MA, Trojanowski JQ, Wolk DA, Lee VM, Arnold SE.

Alzheimers Dement. 2013 Jan;9(1):76-92. doi: 10.1016/j.jalz.2012.02.007. Epub 2012 Nov 22. Review.

14.

Plasma biomarkers of depressive symptoms in older adults.

Arnold SE, Xie SX, Leung YY, Wang LS, Kling MA, Han X, Kim EJ, Wolk DA, Bennett DA, Chen-Plotkin A, Grossman M, Hu W, Lee VM, Mackin RS, Trojanowski JQ, Wilson RS, Shaw LM.

Transl Psychiatry. 2012 Jan 3;2:e65. doi: 10.1038/tp.2011.63.

15.

Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A.

Gold PW, Pavlatou MG, Carlson PJ, Luckenbaugh DA, Costello R, Bonne O, Csako G, Drevets WC, Remaley AT, Charney DS, Neumeister A, Kling MA.

Neurosci Lett. 2012 Jun 27;520(1):1-5. doi: 10.1016/j.neulet.2012.04.072. Epub 2012 May 8.

PMID:
22579817
16.

A review of respiratory system anatomy, physiology, and disease in the mouse, rat, hamster, and gerbil.

Kling MA.

Vet Clin North Am Exot Anim Pract. 2011 May;14(2):287-337, vi. doi: 10.1016/j.cvex.2011.03.007. Review.

PMID:
21601816
17.

Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.

Grillon C, Heller R, Hirschhorn E, Kling MA, Pine DS, Schulkin J, Vythilingam M.

Biol Psychiatry. 2011 Mar 15;69(6):549-55. doi: 10.1016/j.biopsych.2010.12.013. Epub 2011 Jan 31.

18.

11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6'-dimycolate.

Abbott AN, Guidry TV, Welsh KJ, Thomas AM, Kling MA, Hunter RL, Actor JK.

Neuroimmunomodulation. 2009;16(3):147-54. doi: 10.1159/000204227. Epub 2009 Feb 24.

PMID:
19246936
19.

Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Kling MA, Coleman VH, Schulkin J.

Depress Anxiety. 2009;26(7):641-9. doi: 10.1002/da.20546. Review.

20.

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.

Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA.

Biol Psychiatry. 2009 Mar 15;65(6):489-94. doi: 10.1016/j.biopsych.2008.11.010. Epub 2008 Dec 21.

21.

Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.

Regenold WT, Phatak P, Makley MJ, Stone RD, Kling MA.

J Neurol Sci. 2008 Dec 15;275(1-2):106-12. doi: 10.1016/j.jns.2008.07.032. Epub 2008 Sep 9.

22.

CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.

Barr CS, Dvoskin RL, Yuan Q, Lipsky RH, Gupte M, Hu X, Zhou Z, Schwandt ML, Lindell SG, McKee M, Becker ML, Kling MA, Gold PW, Higley D, Heilig M, Suomi SJ, Goldman D.

Arch Gen Psychiatry. 2008 Aug;65(8):934-44. doi: 10.1001/archpsyc.65.8.934.

23.

Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.

Carpenter LL, Bayat L, Moreno F, Kling MA, Price LH, Tyrka AR, Kinkead B, Owens MJ, Nemeroff CB.

Psychiatry Res. 2008 Jan 15;157(1-3):123-9. Epub 2007 Oct 31.

PMID:
17976740
24.

Acute stress potentiates anxiety in humans.

Grillon C, Duncko R, Covington MF, Kopperman L, Kling MA.

Biol Psychiatry. 2007 Nov 15;62(10):1183-6. Epub 2007 Aug 10.

25.

Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.

Kling MA, Alesci S, Csako G, Costello R, Luckenbaugh DA, Bonne O, Duncko R, Drevets WC, Manji HK, Charney DS, Gold PW, Neumeister A.

Biol Psychiatry. 2007 Aug 15;62(4):309-13. Epub 2006 Dec 18.

26.

Activation of blood coagulation in patients with major depressive disorder during euglycemic hyperinsulinemia.

Horne MK 3rd, Merryman PK, Cullinane AM, Cai J, Martinez PE, Kling MA, Gold PW.

Thromb Res. 2007;120(4):517-21. Epub 2006 Dec 8. No abstract available.

27.

Depressive symptoms as a risk factor for osteoporosis and fractures in older Mexican American women.

Tolea MI, Black SA, Carter-Pokras OD, Kling MA.

Osteoporos Int. 2007 Mar;18(3):315-22. Epub 2006 Oct 20.

PMID:
17053870
28.

Number of risk genotypes is a risk factor for major depressive disorder: a case control study.

Garriock HA, Delgado P, Kling MA, Carpenter LL, Burke M, Burke WJ, Schwartz T, Marangell LB, Husain M, Erickson RP, Moreno FA.

Behav Brain Funct. 2006 Jul 5;2:24.

29.

VNS and depression: current status and future directions.

Walsh SP, Kling MA.

Expert Rev Med Devices. 2004 Sep;1(1):155-60. Review.

PMID:
16293018
30.

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P.

Biol Psychiatry. 2005 Sep 1;58(5):364-73.

PMID:
16139582
31.

Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.

Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ.

Biol Psychiatry. 2005 Sep 1;58(5):355-63.

PMID:
16139581
32.

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG.

Biol Psychiatry. 2005 Sep 1;58(5):347-54.

PMID:
16139580
33.

Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance.

Garriock HA, Allen JJ, Delgado P, Nahaz Z, Kling MA, Carpenter L, Burke M, Burke W, Schwartz T, Marangell LB, Husain M, Erickson RP, Moreno FA.

Mol Psychiatry. 2005 Nov;10(11):976-7. No abstract available.

PMID:
16027738
34.

Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia.

Gold PW, Wong ML, Goldstein DS, Gold HK, Ronsaville DS, Esler M, Alesci S, Masood A, Licinio J, Geracioti TD Jr, Perini G, DeBellis MD, Holmes C, Vgontzas AN, Charney DS, Chrousos GP, McCann SM, Kling MA.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8303-8. Epub 2005 May 26.

35.

Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.

Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, Chrousos GP, Gold PW.

J Clin Endocrinol Metab. 2005 May;90(5):2522-30. Epub 2005 Feb 10.

PMID:
15705924
36.

Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.

Dominitz JA, Boyko EJ, Koepsell TD, Heagerty PJ, Maynard C, Sporleder JL, Stenhouse A, Kling MA, Hrushesky W, Zeilman C, Sontag S, Shah N, Ona F, Anand B, Subik M, Imperiale TF, Nakhle S, Ho SB, Bini EJ, Lockhart B, Ahmad J, Sasaki A, van der Linden B, Toro D, Martinez-Souss J, Huilgol V, Eisen S, Young KA.

Hepatology. 2005 Jan;41(1):88-96.

PMID:
15619249
37.

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.

Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.

Biol Psychiatry. 2004 Sep 15;56(6):418-26.

PMID:
15364040
38.

Treatment outcomes in depression: comparison of remote treatment through telepsychiatry to in-person treatment.

Ruskin PE, Silver-Aylaian M, Kling MA, Reed SA, Bradham DD, Hebel JR, Barrett D, Knowles F 3rd, Hauser P.

Am J Psychiatry. 2004 Aug;161(8):1471-6.

PMID:
15285975
39.

Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders.

Regenold WT, Phatak P, Kling MA, Hauser P.

Mol Psychiatry. 2004 Aug;9(8):731-3. No abstract available.

PMID:
15098005
40.

Antithyroid antibody-linked symptoms in borderline personality disorder.

Geracioti TD Jr, Kling MA, Post RM, Gold PW.

Endocrine. 2003 Jul;21(2):153-8.

PMID:
12897379
41.

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

Hauser P, Khosla J, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, Meyers CA, Howell CD.

Mol Psychiatry. 2002;7(9):942-7.

42.

Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.

Kling MA, Carson RE, Borg L, Zametkin A, Matochik JA, Schluger J, Herscovitch P, Rice KC, Ho A, Eckelman WC, Kreek MJ.

J Pharmacol Exp Ther. 2000 Dec;295(3):1070-6.

PMID:
11082442
43.

Prophylactic treatment of depression induced by interferon-alpha.

Hauser P, Soler R, Reed S, Kane R, Gulati M, Khosla J, Kling MA, Valentine AD, Meyers CA.

Psychosomatics. 2000 Sep-Oct;41(5):439-41. No abstract available.

PMID:
11015632
44.

Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders.

Regenold WT, Kling MA, Hauser P.

Psychoneuroendocrinology. 2000 Aug;25(6):593-606.

PMID:
10840171
45.

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.

Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD Jr, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW.

Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):325-30.

46.

Antidepressant effects of nicotine in an animal model of depression.

Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E Jr, Janowsky DS, Kling MA.

Psychopharmacology (Berl). 1999 Feb;142(2):193-9.

PMID:
10102772
47.

Reliability and acceptability of psychiatric diagnosis via telecommunication and audiovisual technology.

Ruskin PE, Reed S, Kumar R, Kling MA, Siegel E, Rosen M, Hauser P.

Psychiatr Serv. 1998 Aug;49(8):1086-8.

PMID:
9712219
48.

Mood and cognitive side effects of interferon-alpha therapy.

Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P.

Semin Oncol. 1998 Feb;25(1 Suppl 1):39-47. Review.

PMID:
9482539
49.

Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.

Licinio J, Kling MA, Hauser P.

Semin Oncol. 1998 Feb;25(1 Suppl 1):30-8. Review.

PMID:
9482538
50.

The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.

Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.

J Neuroendocrinol. 1996 Aug;8(8):579-85.

PMID:
8866244

Supplemental Content

Loading ...
Support Center